Marathon Capital Management’s Oracle ORCL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-3,700
Closed -$390K 162
2023
Q4
$390K Hold
3,700
0.1% 105
2023
Q3
$392K Hold
3,700
0.1% 103
2023
Q2
$441K Hold
3,700
0.11% 102
2023
Q1
$344K Hold
3,700
0.08% 118
2022
Q4
$302K Hold
3,700
0.08% 114
2022
Q3
$226K Hold
3,700
0.06% 131
2022
Q2
$259K Buy
+3,700
New +$271K 0.08% 118
2022
Q1
Sell
-3,700
Closed -$323K 143
2021
Q4
$323K Sell
3,700
-1,036
-22% -$97.3K 0.08% 124
2021
Q3
$413K Buy
4,736
+1,036
+28% +$91.5K 0.09% 120
2021
Q2
$288K Hold
3,700
0.07% 141
2021
Q1
$259K Hold
3,700
0.07% 149
2020
Q4
$239K Hold
3,700
0.07% 128
2020
Q3
$220K Sell
3,700
-238
-6% -$13.5K 0.08% 122
2020
Q2
$218K Buy
+3,938
New +$209K 0.08% 117
2020
Q1
Sell
-3,936
Closed -$208K 137
2019
Q4
$208K Buy
+3,936
New +$217K 0.07% 127

Other funds holding ORCL

Marathon Capital Management's ORCL Position: Q1 2024 in Review

Marathon Capital Management sold out of Oracle (ORCL) in Q1 2024, closing a stake of 3,700 shares — an estimated $390K sold.

Marathon Capital Management first reported a position in ORCL in Q4 2019 and held it in 15 quarters. The position peaked at $441K in Q2 2023. 2,811 funds tracked by Wall St. Rank hold ORCL as of Q1 2024.

  • Marathon Capital Management reported no remaining Oracle position as of Q1 2024 after selling out during the quarter.
  • Marathon Capital Management sold 3,700 Oracle shares in Q1 2024, an estimated $390K.
  • Marathon Capital Management first reported a position in Oracle in Q4 2019 and held it in 15 quarters.
  • Marathon Capital Management's Oracle position peaked at $441K in Q2 2023.
  • 2,811 funds tracked by Wall St. Rank held Oracle as of Q1 2024.

Based on Marathon Capital Management's 13F filing for Q1 2024, filed 15 May 2024.